Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Comparative Study1
- Research Support, U.S. Gov't, Non-P.H.S.1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Biochemistry1
Search Results
Sort by
- Bookedited by Victor KueteContents:
Part I. Diverse degenerative diseases in Africa
1. Diseases in Africa : an overview
2. Management of inflammatory and nociceptive disorders in Africa
3. Burden and health policy of cancers in Africa
5. Management of infectious diseases in Africa
6. Overview of governmental support across Africa toward the development and growth of herbal medicine
7. Preparation, standardization, and quality control of medicinal plants in Africa
Part II. Therapeutic potential of African medicinal spices and vegetables
8. Antimicrobial activities of African medicinal spices and vegetables
9. Anti-inflammatory and anti-nociceptive activities of African medicinal spices and vegetables
10. Anticancer activities of African medicinal spices and vegetables
11. Antiemetic African medicinal spices and vegetables
12. African Medicinal Spices and Vegetables and Their Potential in the Management of Metabolic Syndrome
13. Other health benefits of African medicinal spices and vegetables
Part III. Popular African medicinal spices and vegetables, and their health effects
14. Allium cepa
15. Allium sativum
16. Canarium schweinfurthii
17. Cinnamon species
18. Cymbopogon citratus
19. Curcuma longa
20. Lactuca sativa
21. Mangifera indica L. (Anacardiaceae)
22. Moringa oleifera
23. Myristica fragrans : a review
24. Passiflora edulis
25. Petroselinum crispum. a Review
26. Sesamum indicum
27. African Medicinal Spices of Genus Piper
28. Thymus vulgaris
29. Syzygium aromaticum
Index.Digital Access ScienceDirect 2017 - ArticleHarish Kumar PM, Kassell B.Biochemistry. 1977 Aug 23;16(17):3846-9.The peptide Leu-Val-Lys-Val-Pro-Leu-Val-Arg-Lys-Lys-Ser-Leu-Arg-Gln-Asn-Leu, a known pepsin inhibitor, is derived from the first 16 amino acids of porcine pepsinogen. It was prepared from the activation mixture and was modified by guanidination of its three lysine residues to form homoarginine residues. The modified peptide is a better pepsin inhibitor than the native peptide; for 50% inhibition of the milk clotting action of pepsin at pH 5.3, the molar ratio of peptide to pepsin required is 9 for the native inhibitor and only 2 for the guanidinated inhibitor. The dissociation constants (k1) of the inhibitor-pepsin complexes are 7 X 10(-8) and 1.4 X 10(-8) M for the native and guanidinated peptides, respectively. The guanidinated peptide is more resistant to digestion by pepsin at pH 3.5. The native and modified peptides partially protect pepsin from inactivation at pH 7. Stepwise removal of the amino-terminal Leu-Val-Har residues from the guanidinated inhibitor by Edman degradation decreases the pepsin-inhibiting activity only slightly at the first step, but markedly at the second and third steps. Thus, all of the amino-terminal sequence except the leucine residue is necessary for full activity.